首页/数据集/Additional file 1: Table S1. of miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

Additional file 1: Table S1. of miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

NIAID Data Ecosystem2026-03-09 收录

耐药性前列腺癌

miRNA靶向调控

数据链接：

https://figshare.com/articles/dataset/Additional_file_1_Table_S1_of_miR-375_induces_docetaxel_resistance_in_prostate_cancer_by_targeting_SEC23A_and_YAP1/4671475 数据链接链接失效反馈

官方服务：

资源简介：

miR-375 targeted genes. (XLSX 400 kb)

应用场景：

创建时间：

2017-02-21

耐药性前列腺癌

激素受体靶向治疗

Constitutively active androgen receptor (AR) signaling confers resistance to AR-targeted therapies. Here we show that the ubiquitin-mediated proteolysis pathway plays a critical role in the degradatio

NIAID Data Ecosystem50

Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate Cancer

耐药性前列腺癌

双功能药物开发

Bifunctional agents that simultaneously antagonize and degrade various AR proteins more effectively block the AR signaling pathway, offering a promising strategy for the treatment of mCRPC patients. H

Figshare2025-04-15 更新30

Identification of Selective SWI/SNF Dependencies in Enzalutamide-Resistant Prostate Cancer

耐药性前列腺癌

表观遗传调控

Enzalutamide (ENZA) is a potent second-generation antiandrogen commonly used to treat hormone-sensitive and castration-resistant prostate cancer (CRPC) patients. While initially effective, the respons

NIAID Data Ecosystem10

ADAM9 Up-regulates N-Cadherin via MiR-218 Suppression in Lung Adenocarcinoma Cells

癌症转移机制

miRNA靶向调控

Identification of miRNAs that differentially expressed in brain metastatic cells and were predicted to target CDH2. To investigate which miRNAs could regulate CDH2 expression in brain-metastatic lung

NIAID Data Ecosystem40

GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance

耐药性前列腺癌

激素受体信号通路

Genomic amplification of the androgen receptor (AR) is an established mechanism of antiandrogen resistance in prostate cancer. Here we show that the magnitude of AR signaling output, independent of A

NIAID Data Ecosystem20

Additional file 1: Table S1. of miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

资源简介：

相关数据集